🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 30/03/1993 | 16,58 | 17,18 | 16,34 | 17,12 | +3,99% | 5,04% | 8.565.304 |
| 29/03/1993 | 16,34 | 16,64 | 16,16 | 16,46 | +1,47% | 2,92% | 8.029.357 |
| 26/03/1993 | 16,88 | 16,94 | 16,10 | 16,22 | -4,23% | 4,95% | 11.526.323 |
| 25/03/1993 | 16,52 | 17,06 | 16,34 | 16,94 | +2,16% | 4,33% | 9.452.122 |
| 24/03/1993 | 16,16 | 16,70 | 15,86 | 16,58 | -6,08% | 5,17% | 27.385.288 |
| 23/03/1993 | 17,24 | 17,89 | 17,24 | 17,65 | +3,50% | 3,81% | 6.755.618 |
| 22/03/1993 | 17,06 | 17,18 | 16,70 | 17,06 | -1,04% | 2,80% | 8.886.830 |
| 19/03/1993 | 17,41 | 17,47 | 17,06 | 17,24 | -0,69% | 2,40% | 10.742.838 |
| 18/03/1993 | 17,47 | 17,53 | 17,24 | 17,35 | -0,68% | 1,71% | 9.795.656 |
| 17/03/1993 | 17,89 | 17,95 | 17,35 | 17,47 | -2,98% | 3,33% | 8.458.618 |
| 16/03/1993 | 18,19 | 18,31 | 17,89 | 18,01 | -2,27% | 2,30% | 5.051.360 |
| 15/03/1993 | 18,79 | 18,85 | 18,37 | 18,43 | -1,28% | 2,54% | 3.410.192 |
| 12/03/1993 | 18,37 | 18,73 | 18,19 | 18,67 | -0,32% | 2,92% | 4.439.538 |
| 11/03/1993 | 18,96 | 19,56 | 18,61 | 18,73 | -1,88% | 5,03% | 6.347.526 |
| 10/03/1993 | 18,37 | 19,08 | 18,37 | 19,08 | +4,92% | 3,90% | 8.220.093 |
| 09/03/1993 | 18,19 | 18,25 | 17,95 | 18,19 | -0,33% | 1,64% | 4.635.514 |
| 08/03/1993 | 17,89 | 18,25 | 17,65 | 18,25 | +2,00% | 3,33% | 5.692.946 |
| 05/03/1993 | 17,95 | 18,25 | 17,77 | 17,89 | -0,66% | 2,66% | 5.094.118 |
| 04/03/1993 | 18,49 | 18,55 | 17,95 | 18,01 | -2,27% | 3,23% | 4.461.126 |
| 03/03/1993 | 18,55 | 18,55 | 18,31 | 18,43 | -0,64% | 1,29% | 3.933.144 |
| 02/03/1993 | 18,67 | 18,67 | 18,37 | 18,55 | -1,58% | 1,60% | 4.900.867 |
| 01/03/1993 | 18,73 | 19,02 | 18,49 | 18,85 | +2,60% | 2,87% | 5.949.077 |
| 26/02/1993 | 18,49 | 18,49 | 18,25 | 18,37 | +0,33% | 1,29% | 3.678.690 |
| 25/02/1993 | 18,19 | 18,37 | 18,01 | 18,31 | +0,00% | 1,97% | 6.002.315 |
| 24/02/1993 | 17,89 | 18,43 | 17,83 | 18,31 | +1,99% | 3,33% | 8.125.563 |
| 23/02/1993 | 17,53 | 18,19 | 17,18 | 17,95 | +2,73% | 5,78% | 9.666.752 |
| 22/02/1993 | 17,77 | 17,83 | 17,06 | 17,47 | -0,68% | 4,36% | 10.278.574 |
| 19/02/1993 | 18,19 | 18,25 | 17,35 | 17,59 | -2,64% | 4,92% | 9.538.896 |
| 18/02/1993 | 18,19 | 18,25 | 17,65 | 18,07 | +1,00% | 3,28% | 8.871.320 |
| 17/02/1993 | 18,07 | 18,13 | 17,71 | 17,89 | -0,99% | 2,31% | 9.614.981 |